
|Videos|October 6, 2017
What Were the Top-line Data Results from the LEAP-1 Study?
Author(s)Contagion® Editorial Staff
Steven Gelone, PharmD, shares the topline data yielded from the LEAP-1 study.
Advertisement
Steven Gelone, PharmD, chief scientific officer at Nabriva Therapeutics, shares the topline data yielded from the LEAP-1 study.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
10 Infectious Disease Developments That Defined Q2 2026
2
FDA Grants Priority Review for Dolutegravir in Newborns With HIV
3
Merck, ADAP Crisis Task Force Agree to Expand IDVYNSO Access in HIV
4
HIV in 2026: Four Experts on Aging, Testing, Equity, and Prevention's Next Era
5



























































































































































































